IM Cannabis (IMCC) is scheduled to report Q3 earnings on November 12, 2026.
IM Cannabis has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, IM Cannabis has averaged an EPS surprise of 0.64% and a revenue surprise of 0.18%.
Earnings Date
Aug 13
EPS
$-0.340
Quarterly Revenue
$5.48M
Annual Revenue
$50.91M
as of Mar 31
Analyze the earnings history of IM Cannabis using advanced sorting and filters.
The chart below shows IM Cannabis's reported EPS compared to analyst estimates over recent quarters.
The chart below shows IM Cannabis's reported revenue compared to analyst estimates over recent quarters.
IM Cannabis (IMCC) is scheduled to report earnings on November 12, 2026. The last reported earnings were for reported on August 13, 2026 for Q2.
The Actual EPS was $-0.34, which missed the estimate of $0.
The Actual Revenue was $5.48M, which beat the estimate of $0.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 31, 2025 | $-0.23 | $-0.39 | 41.0 % |
| Q3 | Nov 14, 2024 | $-0.30 | $-1.41 | 78.7 % |
| Q2 | Aug 14, 2024 | $-0.17 | $-0.85 | 80.0 % |
| Q1 | May 8, 2024 | $-1.86 | $-1.20 | -55.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 31, 2025 | $9.54M | $10.43M | -8.58 % |
| Q3 | Nov 14, 2024 | $10.18M | $15.60M | -34.8 % |
| Q2 | Aug 14, 2024 | $10.78M | $9.57M | 12.7 % |
| Q1 | May 8, 2024 | $8.95M | $10.60M | -15.6 % |